US+1 646-781-8004
Europe+44-203-868-8738
APAC+91-744-778-0008
sales@meticulousresearch.com
Home Report
Store
Immunoassay Market
Immunoassay Market by Product & Solutions (Immunoassay Kits {ELISA, Rapid Tests}, Immunoassay Analyzers, Software & Services), Platform (Chemiluminescence, Radioimmunoassay), Application (Infectious Diseases, Oncology, Allergy), End User - Forecast to 2028
Report ID:MRHC - 104278 Pages: 248 Jul-2021 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Immunoassay Market is expected to reach $46.49 billion by 2028, at a CAGR of 7.5% during the forecast period of 2021 to 2028. The increasing prevalence of acute and chronic infectious diseases coupled with the rising geriatric population, growing awareness for early disease diagnosis, technological advancements in immunoassays, increasing use of immunoassays in oncology and drug & alcohol testing, and the emergence of COVID-19 are the key factors driving the growth of the immunoassays market. In addition, increasing epidemic potentials, integration of microfluidics technology into immunoassays, and emerging economies offer significant growth opportunities for the players operating in this market.
Impact of COVID-19 on the Immunoassays Market
The COVID-19 pandemic has adversely hit many economies around the globe. The pandemic has affected more than 100 countries. In this global pandemic, although many dedicated healthcare professionals are working tirelessly against this crisis, it is important to minimize disease spread by preparing kits for early diagnosis. Testing is one of the essential tools in understanding and managing the coronavirus. As molecular diagnostic tests such as PCR cannot be used to monitor disease progression, there is a greater demand for immunological assays.
Further, the COVID-19 outbreak has impacted the immunoassays market in three areas, i.e., price impact, impact on demand, and impact on the supply chain.
- Price Impact: The need for immunoassay kits for reliable COVID 19 testing has urged governments in many countries to bring down these test prices, making them affordable for everyone. In some government laboratories, these kits are available free of cost. Because of the pandemic, there is an expansion in the adoption of immunoassay products even though there is a reduction in these kits' prices.
- Effect on Demand: Due to the disadvantages conferred by the molecular assays, there is greater demand for immunoassays. Further, immunoassays have a vital part to play in vaccine development, thereby increasing its demand. For instance, lateral flow immunoassays are the rapid diagnostic tests used to detect viral antigens within 10-30 minutes.
- Effect on the Supply Chain: Due to the emergence of COVID-19, several impositions have been laid down by government bodies in several countries, including lockdown leading to the ban of goods throughout the country’s borders. This has led to a shortage in the supply of immunoassay kits. Although there was a disruption in the supply chain, companies were able to maintain the supply chain due to government bodies and manufacturers' joint efforts.
Amidst the pandemic, manufacturers are contributing by developing various diagnostic kits and assays for early disease diagnosis, driving the growth of the immunoassay market. For instance, in February 2021, Agilent Technologies Inc. (U.S.) launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit used for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.
Click here to: Get Free Sample Pages of this Report
Technological advancements in immunoassay techniques are propelling the growth of the immunoassays market
ELISA is the most widely used immunoassay technique for the diagnosis of infectious diseases. This technique is used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Some examples include diagnosis of HIV infection, pregnancy tests, and measurement of cytokines or soluble receptors in cell supernatant or serum.
With the development of signal generation methods, the attention has shifted to the development of immunochemical methods and instruments to provide convenient, high-performance systems. Important advances have been made in the design of immunochemical approaches that allow small molecules, such as metabolites and toxins, to substitute dynamic format assays with non-competitive formats, bringing advantages previously seen only with large molecular analytes. Further, the continuous development of new biomarkers, cost-benefit, and growing adoption of automated platforms for ELISA are expected to increase this technology's adoption.
Bispecific antibodies and recombinant proteins are also beginning to impact immunodiagnostics. Due to the growing acceptance of smart devices, companies are developing automated lateral flow readers connected to mobile phones or laptops. They can produce highly sensitive and quantifiable results, capture and transmit real-time data. Also, there has been high adoption of smart devices in healthcare systems for analysis and data management.
Integration of microfluidics technology in immunoassays offer lucrative growth opportunities
Immunoassays have long been widely used in various applications, such as medical diagnostics, pharmaceutical analysis, environmental, food safety testing, and basic scientific investigations, because of their simplicity, sensitivity, and specificity. However, most immunoassays include a series of washing, mixing, and incubation steps, which are labor-intensive and time-consuming.
Immunoagents used in immunoassays are relatively expensive. The consumption of the immunoagents can be greatly reduced if the system is miniaturized. Therefore, microfluidic systems, also known as a lab-on-a-chip or a micro-total-analysis-system, have attracted a lot of attention due to their advantages, such as miniaturization, integration, and automation.
Microfluidic devices are a new and diverse technology that uses fluids in micro environments in a controlled manner, distinguishing them from conventional nitrocellulose lateral flow tests. They can be regarded as the ultimate technical solution for miniaturizing protein biomarker immunoassays by uniquely combining the advantages of simplified fluidics, a reduced number of reagents, and much shorter assay times. These devices have used several methods for antibody immobilization, including passive adsorption, which is common with plastic surfaces, covalent binding, where salinization seems to be the base of most covalent binding techniques, and a combination of the two techniques together with some antibody-orientated techniques, which are still not widely used.
Microfluidic protein quantitation is a promising area for the POC diagnosis of non-communicable diseases and severe infections, such as sepsis. Diagnosing these health conditions requires the accurate quantitation of very small amounts of biomarkers present in biological samples. Thus, the integration of microfluidics technology in immunoassay is expected to provide lucrative opportunities for the growth of the immunoassays market.
Key Findings of the Global Immunoassays Market Study:
The ELISA kits and reagents segment is expected to account for the largest share during the forecast period
Increasing prevalence of infectious diseases such as HIV, growing awareness regarding the diagnosis of cancer and autoimmune diseases, and emergence of the coronavirus pandemic are the factors leading to the growth of the segment.
The chemiluminescence immunoassays segment is expected to grow at the highest CAGR during the forecast period
Rising trends towards adoption of chemiluminescence assays in clinical diagnostics, research applications, and pharmaceutical analysis due to their low cost per test are the factors majorly responsible for the growth of this segment during the forecast period.
Based on application, the bone and mineral diseases segment is expected to grow at the highest CAGR during the forecast period
The rising need for the early diagnosis of osteoporosis and monitoring the effectiveness of the treatment and growing demand for vitamin D testing are the factors driving the growth of this segment.
In 2021, the diagnostic reference laboratories segment is expected to account for the largest share of the immunoassays market
Factors contributing to the large share of this segment include the rising laboratory automation, availability of well-equipped systems, growing prevalence of infectious diseases, and rising government initiatives to increase the adoption of immunoassay techniques in diagnostic reference laboratories.
Asia Pacific: Fastest Growing Market
At the regional level, North America is expected to account for the largest share of the immunoassays market in 2021. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The growth in this market is expected to be driven by the increasing prevalence of infectious diseases and cancer, increasing government spending on healthcare, and improved diagnosis and treatment access.
Key Players
The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the past four years. The key players profiled in the global immunoassay market are F. Hoffman-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.) and PerkinElmer, Inc. (U.S.) among others.
Scope of the Report:
Immunoassays Market, by Product & Solution
- Immunoassay Kits and Reagents
- Elisa Kits and Reagents
- Rapid Test Kits and Reagents
- Western Blot Kits and Reagents
- Elispot Kits and Reagents
- Other Immunoassay Kits and Reagents
- Immunoassay Analyzers
- Immunoassay Software and Services
(Other immunoassay kits and reagents comprises radioimmunoassay, microarray immunoassays, immunohistochemistry assays, bead-based immunoassays, and multiplex microarray assays)
Immunoassays Market, by Platform
- Chemiluminescence Immunoassay
- Fluorescence Immunoassay
- Colorimetric Immunoassay
- Radioimmunoassay
- Other Immunoassay Platforms
(Other immunoassay platforms comprise turbidimetric immunoassays, chromatographic immunoassays, microarray immunoassays, immunohistochemistry, and counting immunoassays)
Immunoassays Market, by Application
- Infectious Diseases
- Oncology
- Endocrinology
- Cardiology
- Bone and Mineral Diseases
- Autoimmune Disorders
- Other Applications
(Other applications comprise toxicology, hematology, neonatal testing, allergy, and gastrology.)
Immunoassay Market, by End User
- Diagnostics Reference Laboratories
- Hospitals and Clinics
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Other End Users
(Other end users comprise nursing homes, ambulatory care centers, blood banks, and home healthcare agencies)
Immunoassays Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Australia
- Indonesia
- Rest of APAC (RoAPAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Key questions answered in the report:
The immunoassays market covers the market size & forecasts of consumables like kits and reagents, immunoassay analyzers, and software & services. The immunoassays market studied in this report involves the value analysis of various segments and sub-segments of immunoassays at the regional and country level.
The global immunoassays market is projected to reach $46.50 billion by 2028, at a CAGR of 7.5% during the forecast period.
The immunoassay kits and reagents segment is expected to account for the largest share of the immunoassays market in 2021.
Based on platform, the chemiluminescence immunoassays segment is projected to create more traction due to the increase in the adoption of chemiluminescence assays in clinical diagnostics, research applications, and pharmaceutical analysis.
An increase in the spread of various chronic and infectious diseases, technological advancements in immunoassays, increasing use of immunoassays in oncology and drug & alcohol testing, and the emergence of COVID-19 are the factors supporting the growth of the immunoassay market. Further, the increasing epidemic potentials, integration of microfluidics technology into immunoassays, and emerging economies offer lucrative growth opportunities for the players operating in this market.
The key players operating in the global immunoassay market are F. Hoffman-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.) and PerkinElmer, Inc. (U.S.) among others.
The emerging countries from Asia and Latin America are projected to offer significant growth opportunities for the vendors in this market.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Growing Prevalence of Chronic and Infectious Diseases
4.2.2. Technological Advancements in Immunoassays
4.2.3. Increasing Use of Immunoassays in Oncology
4.2.4. Role of Immunoassays in Drug and Alcohol Testing
4.2.5. Impact of COVID-19
4.3. Restraints
4.3.1. Technical Impediments Concerned with Immunoassay kits
4.3.2. Inadequate Reimbursement Policies for Immunoassays in the U.S. and Europe
4.4. Opportunities
4.4.1. Emerging Economies
4.4.2. Integration of Microfluidics Technology in Immunoassays
5. Immunoassays Market – Regulatory Analysis
5.1. North America
5.2. Europe
5.3. Asia-Pacific
5.4. Latin America and the Middle East & Africa
6. Global Immunoassays Market, by Product & Solution
6.1. Introduction
6.2. Immunoassay Kits & Reagents
6.2.1. Elisa Kits & Reagents
6.2.2. Rapid Test Kits & Reagents
6.2.3. Western Blot Kits & Reagents
6.2.4. Elispot Kits & Reagents
6.2.5. Other Immunoassay Kits & Reagents
6.3. Immunoassay Analyzers
6.4. Immunoassay Software & Services
7. Global Immunoassays Market, by Platform
7.1. Introduction
7.2. Chemiluminescence Immunoassay
7.3. Fluorescence Immunoassay
7.4. Colorimetric Immunoassay
7.5. Radioimmunoassay
7.6. Other Immunoassay Platforms
8. Global Immunoassays Market, by Application
8.1. Introduction
8.2. Infectious Diseases
8.3. Oncology
8.4. Endocrinology
8.5. Cardiology
8.6. Bone and Mineral Diseases
8.7. Autoimmune Disorders
8.8. Other Applications
9. Global Immunoassays Market, by End User
9.1. Introduction
9.2. Diagnostic Reference Laboratories
9.3. Hospitals & Clinics
9.4. Pharmaceutical and Biotechnology Companies
9.5. Academic and Research Institutions
9.6. Other End Users
10. Immunoassays Market, by Geography
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. Italy
10.3.3. France
10.3.4. U.K.
10.3.5. Spain
10.3.6. Rest of Europe (RoE)
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. Indonesia
10.4.6. Rest of Asia-Pacific (RoAPAC)
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Middle East and Africa
11. Competitive Landscape
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2020)
11.4.1. F. Hoffmann-La Roche AG (SWITZERLAND)
11.4.2. Abbott Laboratories (U.S.)
11.4.3. Siemens Healthineers AG (GERMANY)
12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
12.1. F. Hoffmann-La Roche AG
12.2. Siemens Healthineers AG (Subsidiary of Siemens AG)
12.3. Abbott Laboratories
12.4. Danaher Corporation
12.5. Sysmex Corporation
12.6. bioMérieux SA
12.7. Thermo Fisher Scientific Inc.
12.8. Becton, Dickinson and Company
12.9. Merck KGaA
12.10. Bio-Rad Laboratories, Inc.
12.11. Agilent Technologies, Inc.
12.12. PerkinElmer, Inc.
13. Appendix
13.1. Questionnaire
13.2. Available Customization
List of Tables
Table 1 Global Immunoassays Market Drivers: Impact Analysis (2021-2028)
Table 2 Immunoassays for Tumor Markers Analysis
Table 3 Immunological Tests Used to Detect SARS-Cov-2 Virus
Table 4 Global Immunoassays Market Restraints: Impact Analysis (2021-2028)
Table 5 Common Problems with Immunoassays
Table 6 Reimbursement for Few Immunoassays in the U.S.
Table 7 Microfluidic Heterogeneous Immunoassays for Protein Biomarkers Quantitation
Table 8 Policy/Guidelines/Standards in Europe
Table 9 Immunoassay Regulations in Asia-Pacific Region
Table 10 Immunoassay Regulations in the Rest of the World
Table 11 GLOBAL Immunoassays Market Size, by Product & Solution, 2019–2028 (USD MILLION)
Table 12 Types of Reagents Used in Immunoassays
Table 13 Global Immunoassay Kits & Reagents Market Size, by Type, 2019–2028 (USD Million)
Table 14 Immunoassay Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million)
Table 15 Key Companies Offering Elisa Kits & Reagents
Table 16 ELISA Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million)
Table 17 Key Companies Offering Rapid Test Kits & Reagents
Table 18 Rapid Test Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million)
Table 19 Key Companies Offering Western Blot Kits & Reagents
Table 20 Western Blot Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million)
Table 21 ELISPOT Vs. Conventional ELISA
Table 22 Key Companies Offering ELISPOT Kits & Reagents
Table 23 ELISPOT Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million)
Table 24 Other Immunoassay Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million)
Table 25 Some of the Key Companies Offering Immunoassay Analyzers
Table 26 Immunoassay Analyzers Market Size, by Country/Region, 2019–2028 (USD Million)
Table 27 Some of the Key Commercial Immunoassay Software Available in the Global Market
Table 28 Immunoassay Software & Services Market Size, by Country/Region, 2019–2028 (USD Million)
Table 29 GLOBAL Immunoassays Market Size, by Platform, 2019–2028 (USD MILLION)
Table 30 Key Companies Offering Chemiluminescence Immunoassay Products
Table 31 Chemiluminescence Immunoassay Market Size, by Country/Region, 2019–2028 (USD Million)
Table 32 Key Companies Offering Fluorescence Immunoassay Products
Table 33 Fluorescence Immunoassay Market Size, by Country/Region, 2019–2028 (USD Million)
Table 34 Key Companies Offering Colorimetric Immunoassay Products
Table 35 Colorimetric Immunoassay Market Size, by Country/Region, 2019–2028 (USD Million)
Table 36 Key Companies Offering Radioimmunoassay Kits & Reagents
Table 37 Radioimmunoassay Market Size, by Country/Region, 2019–2028 (USD Million)
Table 38 Other Immunoassay Platforms Market Size, by Country/Region, 2019–2028 (USD Million)
Table 39 Global Immunoassays Market Size, by Application, 2019–2028 (USD Million)
Table 40 Rapid Tests for Detecting COVID-19
Table 41 Global HIV Prevalence, by Region (2019)
Table 42 Immunoassays Market Size for Infectious Diseases, by Country/Region, 2019–2028 (USD Million)
Table 43 Global Cancer Incidence and Mortality, by Type (2020)
Table 44 Immunoassays Market Size for Oncology, by Country/Region, 2019–2028 (USD Million)
Table 45 Immunoassays Market Size for Endocrinology, by Country/Region, 2019–2028 (USD Million)
Table 46 Immunoassays Market Size for Cardiology, by Country/Region, 2019–2028 (USD Million)
Table 47 Immunoassays Market Size for Bone and Mineral Diseases, by Country/Region, 2019–2028 (USD Million)
Table 48 Immunoassays Market Size for Autoimmune Disorders, by Country/Region, 2019–2028 (USD Million)
Table 49 Immunoassays Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 50 Global Immunoassays Market Size, by End User, 2019–2028 (USD Million)
Table 51 Immunoassays Market Size for Diagnostic Reference Laboratories, By Country/Region, 2019–2028 (USD Million)
Table 52 Immunoassays Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD MILLION)
Table 53 Immunoassays Market Size for Pharmaceutical and Biotechnology Companies, By Country/Region, 2019–2028 (USD Million)
Table 54 Immunoassays Market Size for Academic and Research Institutions, By Country/Region, 2019–2028 (USD Million)
Table 55 Immunoassays Market Size for Other End Users, by Country/Region, 2019–2028 (USD Million)
Table 56 Global Immunoassays Market Size, by Country/Region, 2019–2028 (USD Million)
Table 57 North America: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million)
Table 58 North America: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 59 North America: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 60 North America: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 61 North America: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 62 North America: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 63 Recent Lateral Flow Assays Product Launches for COVID-19 Testing in U.S.
Table 64 U.S.: Immunoassays Market Size, by Product & Solution, 2019 – 2028 (USD Million)
Table 65 U.S.: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 66 U.S.: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 67 U.S.: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 68 U.S.: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 69 Canada: Immunoassays Market Size, by Product & Solution, 2019 – 2028 (USD Million)
Table 70 Canada: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 71 Canada: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 72 Canada: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 73 Canada: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 74 Europe: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million)
Table 75 Europe: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 76 Europe: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 77 Europe: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 78 Europe: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 79 Europe: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 80 Recent Immunoassay Kits Launched for COVID-19 Testing In Germany
Table 81 Germany: Immunoassays Market Size, By Product & Solutions, 2019 – 2028 (USD Million)
Table 82 Germany: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 83 Germany: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 84 Germany: Immunoassay Market Size, by Application, 2019 – 2028 (USD Million)
Table 85 Germany: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 86 Number Of Cancer Cases, (2019 vs. 2040)
Table 87 Italy: COVID-19 Cases
Table 88 Italy: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 89 Italy: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 90 Italy: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 91 Italy: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 92 Italy: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 93 France: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 94 France: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 95 France: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 96 France: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 97 France: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 98 Number of Acute Respiratory Illness Outbreaks in the U.K. by Institution Type: 2015-2019
Table 99 U.K.: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 100 U.K.: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 101 U.K.: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 102 U.K.: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 103 U.K.: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 104 Spain: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 105 Spain: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD MILLION)
Table 106 Spain: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 107 Spain: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 108 Spain: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 109 COVID-19 Cases in European Countries
Table 110 RoE: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 111 RoE: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 112 RoE: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 113 RoE: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 114 RoE: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 115 Asia-Pacific: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million)
Table 116 Asia-Pacific: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 117 Asia-Pacific: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 118 Asia-Pacific: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 119 Asia-Pacific: Immunoassay Market Size, by Application, 2019 – 2028 (USD Million)
Table 120 Asia-Pacific: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 121 Japan: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 122 Japan: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 123 Japan: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 124 Japan: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 125 Japan: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 126 China: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 127 China: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 128 China: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 129 China: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 130 China: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 131 India: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 132 INDIA: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 133 India: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 134 India: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 135 India: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 136 Australia: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 137 Australia: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 138 Australia: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 139 Australia: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 140 Australia: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 141 Indonesia: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 142 Indonesia: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 143 Indonesia: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 144 Indonesia: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 145 Indonesia: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 146 RoAPAC: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 147 RoAPAC: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 148 RoAPAC: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 149 RoAPAC: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 150 RoAPAC: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 151 Latin America: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million)
Table 152 Latin America: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 153 Latin America: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 154 Latin America: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 155 Latin America: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 156 Latin America: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 157 Brazil: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 158 Brazil: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 159 Brazil: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 160 Brazil: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 161 Brazil: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 162 Some Immunoassays Validated by the National Institute for Epidemiological Diagnosis and Reference (Indre) in Mexico
Table 163 Mexico: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 164 Mexico: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 165 Mexico: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 166 Mexico: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 167 Mexico: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 168 Disease Prevalence and top Causes of Deaths (2019)
Table 169 Rest of Latin America: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 170 Rest of Latin America: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 171 Rest of Latin America: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 172 Rest of Latin America: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 173 Rest of Latin America: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 174 Middle East & Africa: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million)
Table 175 Middle East & Africa: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million)
Table 176 Middle East & Africa: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million)
Table 177 Middle East & Africa: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million)
Table 178 Middle East & Africa: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million)
Table 179 Recent Developments, by Company, 2018—2021
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Immunoassays Market Size, by Product & Solution, 2021 vs. 2028 (USD Million)
Figure 8 Global Immunoassays Market Size, by Platform, 2021 vs. 2028 (USD Million)
Figure 9 Global Immunoassays Market Size, by Application, 2021 vs. 2028 (USD Million)
Figure 10 Diagnostic Reference Laboratories to Dominate the Immunoassays Market, by End User (2021 vs. 2028)
Figure 11 Immunoassays Market, by Region
Figure 12 Market Dynamics
Figure 13 Global Diabetes Prevalence by Age and Sex in 2019
Figure 14 Global Immunoassays Market Size, by Product & Solution, 2021–2028 (USD Million)
Figure 15 Number of People Living with HIV Worldwide, 2015–2019 (Million)
Figure 16 Global Immunoassays Market Size, by Platform, 2021–2028 (USD Million)
Figure 17 Global Immunoassays Market Size, by Application, 2021–2028 (USD Million)
Figure 18 Global Immunoassays Market Size, by End User, 2021–2028 (USD Million)
Figure 19 Hospital Admissions Due to COVID-19 (2020–2021)
Figure 20 Global Immunoassays Market, by Region, 2021 – 2028 (USD Million)
Figure 21 Geographic Snapshot: North American Immunoassays Market
Figure 22 Geographic Snapshot: European Immunoassays Market
Figure 23 France: The Share of Older People (65 Years and Above), 2012-2050
Figure 24 Geographic Snapshot: Asia-Pacific Immunoassays Market
Figure 25 Japan: Share of Geriatric Population in total Population (65 And Over)
Figure 26 Key Growth Strategies Adopted by Leading Players, 2018—2021
Figure 27 Immunoassays Market: Competitive Benchmarking, by Product
Figure 28 Market Share Analysis: Immunoassays Industry, 2020
Figure 29 F. Hoffmann-La Roche AG: Financial Overview, 2020
Figure 30 Siemens Healthineers AG.: Financial Overview, 2020
Figure 31 Abbott Laboratories.: Financial Overview, 2020
Figure 32 Danaher Corporation: Financial Overview, 2020
Figure 33 Sysmex Corporation.: Financial Overview, 2020
Figure 34 bioMérieux SA: Financial Overview, 2020
Figure 35 Thermo Fisher Scientific Inc: Financial Overview, 2020
Figure 36 Becton, Dickinson and Company: Financial Overview, 2020
Figure 37 Merck KGaA: Financial Overview, 2020
Figure 38 Bio-Rad Laboratories, Inc.: Financial Overview, 2020
Figure 39 Agilent Technologies, Inc.: Financial Overview, 2020
Figure 40 PerkinElmer, Inc.: Financial Overview, 2021
COVID-19
This report provides pre & post COVID-19 market estimates.
Related Reports
Tissue Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: Sep-2022
HLA Typing Market - Global Opportunity Analysis And Industry Forecast (2022-2029)
Published Date: Jun-2022
NGS Automation Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: Jun-2022
Rapid Diagnostics Market - Global Opportunity Analysis and Industry Forecast ( 2022-2029)
Published Date: May-2022
